Yayın: Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies
| dc.contributor.author | BEYDEMİR, ŞÜKRÜ | |
| dc.contributor.author | Cüneyt Türkeş | |
| dc.contributor.author | Mustafa Arslan | |
| dc.contributor.author | Yeliz Demir | |
| dc.contributor.author | Büşra Dinçer | |
| dc.contributor.author | Abdulilah Ece | |
| dc.contributor.author | Ömer İrfan Küfrevioğlu | |
| dc.contributor.author | Şükrü Beydemir | |
| dc.contributor.orcid | 0000-0002-4803-845X | |
| dc.contributor.orcid | 0000-0002-2932-2789 | |
| dc.contributor.orcid | 0000-0003-0796-4374 | |
| dc.contributor.orcid | 0000-0003-3216-1098 | |
| dc.contributor.orcid | 0000-0002-3365-7741 | |
| dc.contributor.orcid | 0000-0002-3087-5145 | |
| dc.contributor.orcid | 0000-0002-1877-3154 | |
| dc.contributor.orcid | 0000-0003-3667-6902 | |
| dc.date.accessioned | 2025-11-13T09:08:29Z | |
| dc.date.issued | 2024-02-19 | |
| dc.identifier.doi | https://doi.org/10.1016/j.bioorg.2024.107221 | |
| dc.identifier.endpage | 107221 | |
| dc.identifier.issn | 0045-2068 | |
| dc.identifier.openalex | W4391934151 | |
| dc.identifier.startpage | 107221 | |
| dc.identifier.uri | https://hdl.handle.net/11421/571 | |
| dc.identifier.uri | https://doi.org/10.1016/j.bioorg.2024.107221 | |
| dc.identifier.volume | 145 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Bioorganic Chemistry | |
| dc.rights | restrictedAccess | |
| dc.subject | Aldose reductase | |
| dc.subject | Chemistry | |
| dc.subject | Aldehyde Reductase | |
| dc.subject | Cytotoxicity | |
| dc.subject | Polyol pathway | |
| dc.subject | Diabetic retinopathy | |
| dc.subject | Cataracts | |
| dc.subject | Aldose reductase inhibitor | |
| dc.subject | Pharmacology | |
| dc.subject | Nephropathy | |
| dc.subject | Diabetes mellitus | |
| dc.subject | Diabetic nephropathy | |
| dc.subject | Biochemistry | |
| dc.subject | Enzyme | |
| dc.subject | In vitro | |
| dc.subject | Medicine | |
| dc.subject | Endocrinology | |
| dc.subject | Ophthalmology | |
| dc.subject.sdg | 3 | |
| dc.title | Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5081967794 |
